Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online
Fast & Reliable Delivery
Ongoing Support
Ingredients From The US
Discreet Shipping
100% Online SpadeRX, Inc. and/or its affiliates or subsidiaries (collectively, “Company”, “we”, or “us”) owns and operates the website located at www.SpadeRx.com, and any mobile application related thereto, to provide certain SpadeRX products and services (collectively, the “Service”). Your access and use of the Service requires your consent to the use of telehealth to provide the Services.
The purpose of this consent (“Consent”) is to provide you with information about telehealth and to obtain your informed consent to the use of telehealth in the delivery of SpadeRX services to you by certain SpadeRX personnel (“Providers”). In this Consent, the terms “you” and “yours” refer to the person using the Service.
BY CLICKING “I AGREE,” CHECKING A RELATED BOX TO SIGNIFY YOUR ACCEPTANCE, USING ANY OTHER ACCEPTANCE PROTOCOL PRESENTED THROUGH THE SERVICE, OR BY USING TELEHEALTH DURING THE USE OF THE SERVICE, YOU ACKNOWLEDGE THAT YOU HAVE READ, ACCEPTED, AND AGREED TO BE BOUND BY THIS CONSENT. IF YOU DO NOT AGREE TO THIS CONSENT, DO NOT CREATE AN ACCOUNT OR USE THE SERVICE.
Telehealth involves the delivery of SpadeRX services using electronic communications, information technology or other means between a SpadeRX provider and a patient who are not in the same physical location. Telehealth may be used for diagnosis, treatment, follow-up and/or patient education, and may include but is not limited to one or more of the following:
There may be potential risks associated with the use of telehealth and other technology. These risks include but may not be limited to the following:
The electronic systems used in the Service will incorporate network and software security protocols to protect the privacy and security of your information and will include measures to safeguard data against intentional or unintentional corruption. Use of the Service may include email communications to and from you that may include your protected health information. You understand that Company does not and cannot guarantee the security or privacy of the services you use to receive communications, including your email service provider.
You have the right to withdraw your consent to the use of telehealth at any time; however, our Providers solely use telehealth to provide the SpadeRX services and you will need to seek treatment from another provider after you withdraw your consent. Any withdrawal of your consent will be effective upon receipt of written notice to your Providers. Any withdrawal of your consent will not affect any other provision of this Consent, and you will continue to be bound by this Consent.
SpadeRx provides access to compounded medications for qualified patients. Compounded medications are not FDA-approved and may differ in risks, benefits, and side effects compared to FDA-approved products. A licensed provider will perform a telehealth Good Faith Exam (GFE) to determine patient eligibility before any prescription is issued. Not all patients are candidates, and individual results may vary. Novo Nordisk Inc. and Eli Lilly and Company are the only U.S. manufacturers of FDA-approved semaglutide (Rybelsus®, Ozempic®, Wegovy®) and tirzepatide (Zepbound®, Mounjaro®), respectively. These manufacturers do not supply their medications for compounding.
Have A Question?